ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Theralase Technologies Inc (QB)

Theralase Technologies Inc (QB) (TLTFF)

0,1904
0,0054
(2,92%)
Fermé 21 Janvier 10:00PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
0,1904
Prix Achat
0,185
Prix Vente
0,25
Volume échangé
37 067
0,185 Fourchette du Jour 0,1968
0,08 Plage de 52 semaines 0,27
Cap du marché
Clôture Veille
0,185
Ouverture
0,1873
Dernière Transaction
1000
@
0.1904
Dernière heure de transaction
Volume financier
US$ 7 015
VWAP
0,189241
Volume moyen (3 m)
56 371
Actions en circulation
242 818 035
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-14,89
Bénéfice par action (BPA)
-0,02
Chiffre d'affairess
1,07M
Bénéfice net
-4,57M

À propos de Theralase Technologies Inc (QB)

Secteur
Electromedical Apparatus
Industrie
Electromedical Apparatus
Siège social
Toronto, Ontario, Can
Fondé
-
Theralase Technologies Inc (QB) est coté dans le secteur Electromedical Apparatus de la OTCMarkets avec le ticker TLTFF. Le dernier cours de clôture d'Theralase Technologies (QB) était de US$0,19. Au cours de la dernière année, les actions de Theralase Technologies (QB) ont été négociées dans une fourchette de prix de US$ 0,08 à US$ 0,27.

Theralase Technologies (QB) compte actuellement 242 818 035 actions en circulation. La capitalisation boursière d'Theralase Technologies (QB) est de US$44,92 million. Theralase Technologies (QB) a un ratio cours/bénéfice (ratio PE) de -14.89.

TLTFF Dernières nouvelles

Theralase Anti-Cancer Technology Picks Up Steam

  Toronto, ON - January 06, 2015 - InvestorsHub Newswire - There are many different approaches to treating cancer, ranging from Roche Holding Ltd.’s (OTC: RHHBY) monoclonal...

Theralase(TM) Technologies Inc. Advances Research on Laser-Activated Photodynamic Compounds for Cancer Treatment

TORONTO, July 23 /PRNewswire-FirstCall/ -- Theralase(TM) Technologies Inc. (TSX-V: TLT & OTC BB: TLTFF) announces that it has entered an agreement with University Health Network (UHN) and...

Theralase Technologies Inc. Announces Financial Results for 1st Quarter Fiscal 2007

TORONTO, May 16 /PRNewswire-FirstCall/ -- Theralase Technologies Inc. (TSXV: TLT & OTC BB: TLTFF) presents unaudited interim financial results for the 3 month period ended March 31st, 2007. 3...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.0268-12.33885819520.21720.2260.1815655390.19535075CS
40.0100555.575424880090.1803450.240.166553270.19802094CS
12-0.0493-20.56737588650.23970.246150.1546563710.19371271CS
260.059245.12195121950.13120.270.08545480.18561837CS
520.060146.12432847280.13030.270.08594210.15769117CS
156-0.0608-24.20382165610.25120.380.08773300.21498059CS
260-0.073-27.71450265760.26340.380.0761046860.19270028CS

TLTFF - Frequently Asked Questions (FAQ)

What is the current Theralase Technologies (QB) share price?
The current share price of Theralase Technologies (QB) is US$ 0,1904
How many Theralase Technologies (QB) shares are in issue?
Theralase Technologies (QB) has 242 818 035 shares in issue
What is the market cap of Theralase Technologies (QB)?
The market capitalisation of Theralase Technologies (QB) is USD 44,92M
What is the 1 year trading range for Theralase Technologies (QB) share price?
Theralase Technologies (QB) has traded in the range of US$ 0,08 to US$ 0,27 during the past year
What is the PE ratio of Theralase Technologies (QB)?
The price to earnings ratio of Theralase Technologies (QB) is -14,89
What is the cash to sales ratio of Theralase Technologies (QB)?
The cash to sales ratio of Theralase Technologies (QB) is 63,64
What is the reporting currency for Theralase Technologies (QB)?
Theralase Technologies (QB) reports financial results in CAD
What is the latest annual turnover for Theralase Technologies (QB)?
The latest annual turnover of Theralase Technologies (QB) is CAD 1,07M
What is the latest annual profit for Theralase Technologies (QB)?
The latest annual profit of Theralase Technologies (QB) is CAD -4,57M
What is the registered address of Theralase Technologies (QB)?
The registered address for Theralase Technologies (QB) is 41 HOLLINGER ROAD, TORONTO, ONTARIO, M4B 3G4
What is the Theralase Technologies (QB) website address?
The website address for Theralase Technologies (QB) is www.theralase.com
Which industry sector does Theralase Technologies (QB) operate in?
Theralase Technologies (QB) operates in the ELECTROMEDICAL APPARATUS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TMGIMarquie Group Inc (PK)
US$ 0,0002
(19 900,00%)
4,03M
SEANSAEAN Group Inc (PK)
US$ 1,87
(18 600,00%)
100
ZPASZoompass Holdings Inc (CE)
US$ 0,0001
(9 900,00%)
675
GMPRGourmet Provisions International Corporation (PK)
US$ 0,0001
(9 900,00%)
35,31M
PLPLPlandai Biotechnology Inc (PK)
US$ 0,0001
(9 900,00%)
18,06M
STNXStartronix International Inc (CE)
US$ 0,000001
(-99,99%)
450
AWINAERWINS Technologies Inc (CE)
US$ 0,000001
(-99,97%)
2,03k
ISOLImage Software Inc (CE)
US$ 0,000001
(-99,91%)
59,2k
NBIONascent Biotech Inc (CE)
US$ 0,0002
(-99,55%)
8,7k
FHBCFernhill Beverage Inc (CE)
US$ 0,000001
(-99,24%)
10k
GTCHGBT Technologies Inc (PK)
US$ 0,0001
(0,00%)
349,77M
VTXBVortex Brands Company (PK)
US$ 0,0002
(0,00%)
297,52M
EMEDElectroMedical Technologies Inc (PK)
US$ 0,0002
(0,00%)
233,53M
PHILPHI Group Inc (PK)
US$ 0,0002
(-33,33%)
184,12M
HMBLHUMBL Inc (PK)
US$ 0,0009
(-5,26%)
179,2M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées